Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism FBXO31 inhibitors(F-box protein 31 inhibitors), Ubiquitin ligase inhibitors(E3 ubiquitin ligase components inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 08 Apr 2025 | |
Diabetes Mellitus | Discovery | - | 08 Apr 2025 | |
Neoplasms | Discovery | - | 08 Apr 2025 | |
Nervous System Diseases | Discovery | - | 08 Apr 2025 | |
Other Diseases | Discovery | - | 08 Apr 2025 |